Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event

Core Insights - Serina Therapeutics' CEO, Steven Ledger, will present at a webinar discussing the impact of new FDA initiatives on drug development and investor expectations in the life sciences sector [1][2] Company Overview - Serina Therapeutics is a clinical-stage biotechnology company focused on developing drug candidates for neurological diseases and other indications using its proprietary POZ Platform™ [5] - The POZ Platform™ aims to enhance the efficacy and safety profiles of various drug modalities, including small molecules, RNA-based therapeutics, and antibody-drug conjugates (ADCs) [5] Event Details - The webinar titled "Navigating the New FDA Era: 2026 Strategic Priorities and the Future of Life Sciences" is scheduled for February 4, 2026, at 8:30 AM Pacific / 11:30 AM Eastern [1] - Participants can submit questions for the CEO before and during the event, which will be hosted by Tribe Public's Managing Member, John F. Heerdink, Jr. [4]